Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The first artificial cell organelle may help researchers find a way to make bioengineered heparin and other synthetic drugs.
Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine.
Researchers at the Venter Institute explain their groundbreaking techniques.
Scientists use synthetic biology to create drug-controlled T cells.
Such microorganisms might make environmental sensors or drug delivery systems.
Ginkgo BioWorks aims to push synthetic biology to the factory level.